It is postulated that due to the orthologous relationship between LILRB2 and PirB, LILRB2 may contribute to Alzheimer’s disease neuropathology, and might be a suitable therapeutic target. Here, LILRB1 is linked to early-onset autosomal dominant Alzheimer disease.